The recent disruptions in global chains have highlighted the value of securing essential medications like Ivermectin. Dependence on overseas manufacturers exposes countries to potential vulnerabilities, including shipping delays, cost fluctuations, and even political concerns. Moving towards domestic sourcing of Ivermectin offers a multitude of ben